Vice President, Sales and Field Leadership jobs in United States
cer-icon
Apply on Employer Site
company-logo

Immunome, Inc. · 2 weeks ago

Vice President, Sales and Field Leadership

Immunome, Inc. is a clinical-stage targeted oncology company committed to developing innovative cancer therapies. They are seeking a proven commercial leader to drive the launch of their first commercial therapy and build the Field Sales and Field Market Access organizations, focusing on patient access and engagement in oncology practices nationwide.

BiopharmaBiotechnologyMedicalPharmaceutical

Responsibilities

Develop and execute the national field launch plan for varegacestat, including sales deployment, field access strategy, customer segmentation, and readiness planning
Partner closely with the Market Access function and Patient Services to ensure seamless payer coverage, affordability, and access across the patient journey
Collaborate cross-functionally with Marketing, Medical Affairs, and Corporate Communications to ensure consistent, compliant, and impactful field messaging
Build and deliver launch readiness frameworks that align sales, field market access, and TLL teams behind a unified go-to-market strategy
Recruit, hire, and develop the founding field organization, including Sales, Field Market Access, and TLL teams
Establish a high-performance culture rooted in accountability, collaboration, and patient focus
Develop best-in-class training, coaching, and performance systems to ensure excellence and consistency across teams
Define KPIs and incentive structures that align field execution with launch and business objectives
Lead the Field Market Access team, ensuring proactive engagement with payers, IDNs, GPOs, and key oncology practices to support product access and reimbursement
Partner with internal Market Access leadership on strategy execution, translating national policy and payer dynamics into actionable field insights
Drive collaboration between sales and field access teams to optimize pull-through and ensure aligned customer engagement
Monitor and report access trends, regional dynamics, and stakeholder feedback to inform strategy and execution
Build and lead the Market Development team, cultivating relationships with top oncology experts and treatment networks
Guide field engagement to be insight-driven, compliant, and deeply patient-centered
Ensure cross-team alignment on key messages, data dissemination, and stakeholder education
Serve as a core member of the Commercial Leadership Team, contributing to launch strategy, forecasting, and resource prioritization
Partner with Market Access, Marketing, Medical, Legal, and Compliance to ensure integrated, compliant field execution
Champion field insights within the organization to inform brand strategy and future indications

Qualification

Oncology experienceField access strategyPayer engagementField sales leadershipCommercial experienceTalent developmentCollaborationTeam buildingStrategic executionAccountability cultureOral oncolytic experienceCommunication skills

Required

Bachelor's degree required
A minimum of 15 years of commercial experience in biotech/pharma, including at least 10 years in oncology field leadership including experience leading leaders
Proven success building and leading field sales and access teams during new product launches
Expertise in field access strategy, payer engagement, and oncology reimbursement landscapes
Demonstrated ability to connect strategy to execution in complex, evolving environments
Known for developing talent, fostering collaboration, and building cultures of accountability
Oral oncolytic experience necessary

Preferred

advanced degree (MBA, MPH, or related)
Experience in both large pharma and emerging biotech organizations is strongly preferred
Commercial sales and/or marketing experience in the sarcoma space preferred

Company

Immunome, Inc.

twittertwittertwitter
company-logo
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.

Funding

Current Stage
Public Company
Total Funding
$998.85M
Key Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M

Leadership Team

leader-logo
Clay Siegall
President and CEO
linkedin
leader-logo
Purnanand D. Sarma
President & CEO
linkedin

Recent News

Company data provided by crunchbase